| View |
|
DRP-11847-06
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Diatech Ultra
|
50 mg / 1 g
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
05 February 2024
|
10 May 2027
|
| View |
|
DRP-12042-01
|
Anastrozole
|
Anastratech
|
1 mg
|
Film-Coated Tablet
|
Aromatase Inhibitor
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
05 February 2024
|
01 June 2027
|
| View |
|
DRP-12987-01
|
Losartan Potassium + Amlodipine (as besilate)
|
None
|
100 mg/10 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Antagonist/Calcium Channel Blocker
|
Ajanta Pharma Limited
|
India
|
CLIDP Conversion
|
09 February 2024
|
03 March 2029
|
| View |
|
DRP-13017-01
|
Telmisartan
|
Normitech
|
40 mg
|
Tablet
|
Angiotension II Receptor Blocker (ARB)
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
09 February 2024
|
17 November 2027
|
| View |
|
DRP-1304-05
|
Mefenamic Acid
|
Paincare
|
500 mg
|
Capsule
|
Non-steroidal Anti-inflammatory Agent (Non-Selective COX Inhibitor)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
03 March 2024
|
28 February 2027
|
| View |
|
DRP-13048-03
|
Salbutamol (as sulfate) + Ipratropium bromide
|
Aetropsal
|
2.5 mg/ 500 mcg per 2.5 mL
|
Solution for Inhalation
|
Selective beta-2-adrenoreceptor agonist/Anticholinergic
|
AHLCON PARENTERALS (INDIA) LIMITED
|
India
|
CLIDP Conversion
|
19 February 2024
|
24 November 2027
|
| View |
|
DRP-13077-01
|
Ursodeoxycholic Acid
|
Goxycholic 250
|
250 mg
|
Film-Coated Tablet
|
Bile Therapy
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
12 February 2024
|
25 November 2027
|
| View |
|
DRP-13127-04
|
Ketoanalogues + Essential Amino Acids
|
Ketoxil
|
(See reverse for formulation)
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 February 2024
|
05 December 2027
|
| View |
|
DRP-13209-01
|
Pregabalin
|
Bagabrit
|
75 mg
|
Capsule
|
Antiepileptic
|
Titan Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
14 February 2024
|
29 December 2027
|
| View |
|
DRP-13222-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Tazofir
|
4g/500mg
|
Powder for Injection (IV)
|
Antibacterial
|
Inject Care Parenterals Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 February 2024
|
26 March 2025
|
| View |
|
DRP-13223-01
|
Rabeprazole sodium + Itopride hydrochloride
|
Reloxa Dos
|
20 mg/ 150 mg
|
Modified-Release Capsule
|
Proton Pump Inhibitor
|
Inventia Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 February 2024
|
24 November 2026
|
| View |
|
DRP-13224-01
|
Paracetamol
|
Parsave
|
10mg/mL (1g/100 mL)
|
Solution for Injection for I.V. Infusion
|
Analgesic/Antipyretic
|
Osel Ilac San. Ve. Tic. A.S
|
Turkey
|
CLIDP Conversion
|
19 January 2024
|
04 January 2028
|
| View |
|
DRP-13229-09
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Glipgludin
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
01 March 2024
|
05 January 2028
|
| View |
|
DRP-13230-05
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Glipgludin
|
100 mg/ 1 g
|
Extended Release Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
: Vill. Mehsa Tibba, P.O. Manjh
|
India
|
CLIDP Conversion
|
06 February 2024
|
05 January 2028
|
| View |
|
DRP-13237-06
|
Ursodeoxycholic Acid
|
Choliva
|
500 mg
|
Film-Coated Tablet
|
Bile Acid and Derivative
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 February 2024
|
06 January 2028
|
| View |
|
DRP-13302-01
|
Colecalciferol (Vitamin D3)
|
D-Supreme
|
1000 IU
|
Softgel Capsule
|
Vitamin
|
Kanion Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
19 January 2024
|
24 January 2028
|
| View |
|
DRP-13356-01
|
Vildagliptin + Metformin Hydrochloride
|
None
|
50 mg/1 g
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
27 February 2024
|
02 February 2028
|
| View |
|
DRP-13365-02
|
Imatinib (as mesylate)
|
Imatech
|
100 mg
|
Film-Coated Tablet
|
Protein-Tyrosine Kinase Inhibitor
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
06 February 2024
|
07 February 2028
|
| View |
|
DRP-13391-02
|
Bleomycin (as Sulfate)
|
Bleoace
|
15 Units
|
Powder for Solution for Injection (IM/IV/SC)
|
Antineoplastic Agent
|
Venus Remedies Limited
|
India
|
CLIDP Conversion
|
22 January 2024
|
16 February 2028
|
| View |
|
DRP-13391-03
|
Bleomycin (as sulfate)
|
Medimycin
|
15 units
|
Powder for Solution for Injection (IM/IV/SC)
|
Antineoplastic agent
|
Venus Remedies, Limited
|
India
|
CLIDP Conversion
|
03 March 2024
|
16 February 2028
|